Following earlier reports, Kobayashi Pharmaceutical confirmed that it has received a preliminary, non-binding joint proposal from NSSK and an affiliate of CVC Capital Partners to take the company private.
The company stated that no decision has been made at this time.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.